MWG Caph Ltd - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, MWG Caph Ltd held in its portfolio 3 assets valued at $72,368,189 (i.e. $72.37M).

The most valuable assets in the portfolio included: BEAM THERAPEUTICS INC ($35.12M), LYELL IMMUNOPHARMA INC ($31.03M), and PRIME MEDICINE INC ($6.22M).

The chart below shows the top 3 valuable assets, and the table below shows the top 3 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in MWG Caph Ltd Portfolio

BEAM THERAPEUTICS INC

LYELL IMMUNOPHARMA INC

PRIME MEDICINE INC

MWG Caph Ltd - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
BEAM THERAPEUTICS INC	1266934	35119410	COM
LYELL IMMUNOPHARMA INC	1008116	31029810	COM NEW
PRIME MEDICINE INC	1792210	6218969	COM